Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geraldine Perkins

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncotarget|July 31, 2019
Ampullary carcinoma prognostic markersGeraldine Perkins, Pierre Laurent-Puig, Julien Taieb
Pharmacogenomics|June 24, 2014
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancerGeraldine Perkins, Camilla Pilati, Helene Blons, et al.
Journal of Cellular Biochemistry|October 16, 2004
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cellsGenevieve M Boland, Geraldine Perkins, David J Hall, et al.
World Journal of Gastroenterology|November 3, 2015
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challengeSimon Pernot, Thibault Voron, Geraldine Perkins, et al.
Cancers|November 27, 2021
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon CancersArnaud Bayle, Debora Basile, Simon Garinet, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French networkGuillaume Perrod, Elia Samaha, Gabriel Rahmi, et al.
Medicine|July 2, 2015
Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin IndexVered Abitbol, Didier Borderie, Vanessa Polin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2017
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, et al.
Cancers|September 9, 2023
Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal MetastasesMaximiliano Gelli, Christophe Desterke, Mohamed Amine Bani, et al.
International Journal of Cancer|January 6, 2010
Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancerGeraldine Perkins, Astrid Lièvre, Carole Ramacci, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncotarget|July 31, 2019
Ampullary carcinoma prognostic markersGeraldine Perkins, Pierre Laurent-Puig, Julien Taieb
Pharmacogenomics|June 24, 2014
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancerGeraldine Perkins, Camilla Pilati, Helene Blons, et al.
Journal of Cellular Biochemistry|October 16, 2004
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cellsGenevieve M Boland, Geraldine Perkins, David J Hall, et al.
World Journal of Gastroenterology|November 3, 2015
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challengeSimon Pernot, Thibault Voron, Geraldine Perkins, et al.
Cancers|November 27, 2021
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon CancersArnaud Bayle, Debora Basile, Simon Garinet, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French networkGuillaume Perrod, Elia Samaha, Gabriel Rahmi, et al.
Medicine|July 2, 2015
Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin IndexVered Abitbol, Didier Borderie, Vanessa Polin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2017
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, et al.
Cancers|September 9, 2023
Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal MetastasesMaximiliano Gelli, Christophe Desterke, Mohamed Amine Bani, et al.
International Journal of Cancer|January 6, 2010
Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancerGeraldine Perkins, Astrid Lièvre, Carole Ramacci, et al.
Pageof 2